Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ZQAIR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
US20220226491A1 Immunoconjugate R1
|
|||||
| Synonyms |
Immunoconjugate R1
Click to Show/Hide
|
|||||
| Organization |
BOLT BIOTHERAPEUTICS, INC. | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
|
|||||
| Drug Status |
Investigative
|
|||||
| Structure |
|
|||||
| Antibody Name |
Atezolizumab
|
Antibody Info | ||||
| Antigen Name |
Programmed cell death 1 ligand 1 (CD274)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||